Association between snus use and lipid status in Swedish men

References

• Peters SA, Singhateh Y, Mackay D, et al. Total cholesterol as a risk factor for coronary heart disease and stroke in women compared with men: a systematic review and meta-analysis. Atherosclerosis. 2016;248:123–131.
   PubMed Web of Science ®Google Scholar
• Duncan MS, Vasan RS, Xanthakis V. Trajectories of blood lipid concentrations over the adult life course and risk of cardiovascular disease and all-cause mortality: observations from the framingham study over 35 years. J Am Heart Assoc. 2019;8(11):e011433.
   PubMed Web of Science ®Google Scholar
• Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet. 2014;384(9943):626–635.
   PubMed Web of Science ®Google Scholar
• Thompson A, Danesh J. Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies. J Intern Med. 2006;259(5):481–492.
   PubMed Web of Science ®Google Scholar
• Virani SS. Non-HDL cholesterol as a metric of good quality of care: opportunities and challenges. Tex Heart Inst J. 2011;38(2):160–162.
   PubMed Web of Science ®Google Scholar
• Brunner FJ, Waldeyer C, Ojeda F, et al. Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the multinational cardiovascular risk consortium. Lancet. 2019;394(10215):2173–2183.
   PubMed Web of Science ®Google Scholar
• Statistical Databases. Statistics Sweden, Stockholm. 2021. https://www.statistikdatabasen.scb.se/pxweb/sv/ssd/START__LE__LE0101__LE0101H/LE01012021H06/. Accessed 21 August 2021
   Google Scholar
• Larsson SC, Mason AM, Back M, et al. Genetic predisposition to smoking in relation to 14 cardiovascular diseases. Eur Heart J. 2020;41(35):3304–3310.
   PubMed Web of Science ®Google Scholar
• Hajat C, Stein E, Ramstrom L, et al. The health impact of smokeless tobacco products: a systematic review. Harm Reduct J. 2021;18(1):123.
   PubMed Web of Science ®Google Scholar
• Arefalk G, Hergens MP, Ingelsson E, et al. Smokeless tobacco (snus) and risk of heart failure: results from two Swedish cohorts. Eur J Prev Cardiol. 2012;19(5):1120–1127.
   PubMed Web of Science ®Google Scholar
• Hansson J, Galanti MR, Hergens MP, et al. Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies. Eur J Epidemiol. 2012;27(10):771–779.
   PubMed Web of Science ®Google Scholar
• Hansson J, Galanti MR, Hergens MP, et al. Snus (Swedish smokeless tobacco) use and risk of stroke: pooled analyses of incidence and survival. J Intern Med. 2014;276(1):87–95.
   PubMed Web of Science ®Google Scholar
• Byhamre ML, Araghi M, Alfredsson L, et al. Swedish snus use is associated with mortality: a pooled analysis of eight prospective studies. Int J Epidemiol. 2021;49(6):2041–2050.
   PubMed Web of Science ®Google Scholar
• Arefalk G, Hambraeus K, Lind L, et al. Discontinuation of smokeless tobacco and mortality risk after myocardial infarction. Circulation. 2014;130(4):325–332.
   PubMed Web of Science ®Google Scholar
• Cluette-Brown J, Mulligan J, Doyle K, et al. Oral nicotine induces an atherogenic lipoprotein profile. Proc Soc Exp Biol Med. 1986;182(3):409–413.
   PubMed Web of Science ®Google Scholar
• Chattopadhyay K, Chattopadhyay BD. Effect of nicotine on lipid profile, peroxidation & antioxidant enzymes in female rats with restricted dietary protein. Indian J Med Res. 2008;127(6):571–576.
   PubMed Web of Science ®Google Scholar
• Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ. 1989;298(6676):784–788.
   PubMedGoogle Scholar
• Kuzuya M, Ando F, Iguchi A, et al. Effect of smoking habit on age-related changes in serum lipids: a cross-sectional and longitudinal analysis in a large Japanese cohort. Atherosclerosis. 2006;185(1):183–190.
   PubMed Web of Science ®Google Scholar
• Jain RB, Ducatman A. Associations between smoking and lipid/lipoprotein concentrations among US adults aged ≥20 years. J Circ Biomark. 2018;7:1849454418779310.
   Google Scholar
• Slagter SN, van Vliet-Ostaptchouk JV, Vonk JM, et al. Associations between smoking, components of metabolic syndrome and lipoprotein particle size. BMC Med. 2013;11:195.
   PubMed Web of Science ®Google Scholar
• Eliasson M, Asplund K, Evrin PE, et al. Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin. The Northern Sweden MONICA study. Atherosclerosis. 1995;113(1):41–53.
   PubMed Web of Science ®Google Scholar
• Byhamre ML, Gustafsson PE, Jansson JH, et al. Snus use during the life-course and risk of the metabolic syndrome and its components. Scand J Public Health. 2017;45(8):733–740.
   PubMed Web of Science ®Google Scholar
• Wallenfeldt K, Hulthe J, Bokemark L, et al. Carotid and femoral atherosclerosis, cardiovascular risk factors and C-reactive protein in relation to smokeless tobacco use or smoking in 58-year-old men. J Intern Med. 2001;250(6):492–501.
   PubMed Web of Science ®Google Scholar
• Norberg M, Stenlund H, Lindahl B, et al. Contribution of Swedish moist snuff to the metabolic syndrome: a wolf in sheep’s clothing? Scand J Public Health. 2006;34(6):576–583.
   PubMed Web of Science ®Google Scholar
• Stegmayr B, Lundberg V, Asplund K. The events registration and survey procedures in the Northern Sweden MONICA project. Scand J Public Health Suppl. 2003;61:9–17.
   PubMedGoogle Scholar
• Eriksson M, Holmgren L, Janlert U, et al. Large improvements in major cardiovascular risk factors in the population of Northern Sweden: the MONICA study 1986–2009. J Intern Med. 2011;269(2):219–231.
   PubMed Web of Science ®Google Scholar
• Lilja M, Eliasson M, Eriksson M, et al. A rightward shift of the distribution of fasting and post-load glucose in Northern Sweden between 1990 and 2009 and its predictors. Data from the Northern Sweden MONICA study. Diabet Med. 2013;30(9):1054–1062.
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806–808.
   PubMed Web of Science ®Google Scholar
• Eriksson M, Forslund AS, Jansson JH, et al. Greater decreases in cholesterol levels among individuals with high cardiovascular risk than among the general population: the Northern Sweden MONICA study 1994 to 2014. Eur Heart J. 2016;37(25):1985–1992.
   PubMed Web of Science ®Google Scholar
• Zeller T, Hughes M, Tuovinen T, et al. BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries. Eur J Epidemiol. 2014;29(10):777–790.
   PubMed Web of Science ®Google Scholar
• White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377–399.
   PubMed Web of Science ®Google Scholar
• Orsini N, Greenland S. A procedure to tabulate and plot results after flexible modeling of a quantitative covariate. Stata J. 2011;11(1):1–29.
   Web of Science ®Google Scholar
• Tobert JA. Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors. Nat Rev Drug Discov. 2003;2(7):517–526.
   PubMed Web of Science ®Google Scholar
• Bruckert E, Rosenbaum D. Lowering LDL-cholesterol through diet: potential role in the statin era. Curr Opin Lipidol. 2011;22(1):43–48.
   PubMed Web of Science ®Google Scholar
• Hansson J, Galanti MR, Magnusson C, et al. Weight gain and incident obesity among male snus users. BMC Public Health. 2011;11:371.
   PubMed Web of Science ®Google Scholar
• Knol MJ, Janssen KJ, Donders AR, et al. Unpredictable bias when using the missing indicator method or complete case analysis for missing confounder values: an empirical example. J Clin Epidemiol. 2010;63(7):728–736.
   PubMed Web of Science ®Google Scholar
• Galea S, Tracy M. Participation rates in epidemiologic studies. Ann Epidemiol. 2007;17(9):643–653.
   PubMed Web of Science ®Google Scholar
• Lundqvist G, Sandström H, Öhman A, et al. Patterns of tobacco use: a 10-year follow-up study of smoking and snus habits in a middle-aged Swedish population. Scand J Public Health. 2009;37(2):161–167.
   PubMed Web of Science ®Google Scholar
• Jaskolowski J, Ritz C, Sjödin A, et al. Weekday variation in triglyceride concentrations in 1.8 million blood samples. J Lipid Res. 2017;58(6):1204–1213.
   PubMed Web of Science ®Google Scholar
• Demacker PN, Schade RW, Jansen RT, et al. Intra-individual variation of serum cholesterol, triglycerides and high density lipoprotein cholesterol in normal humans. Atherosclerosis. 1982;45(3):259–266.
   PubMed Web of Science ®Google Scholar
• Eliasson M, Janlert U, Jansson JH, et al. Time trends in population cholesterol levels 1986–2004: influence of lipid-lowering drugs, obesity, smoking and educational level. The Northern Sweden MONICA study. J Intern Med. 2006;260(6):551–559.
   PubMed Web of Science ®Google Scholar
• Zivkovic AM, Wiest MM, Nguyen UT, et al. Effects of sample handling and storage on quantitative lipid analysis in human serum. Metabolomics. 2009;5(4):507–516.
   PubMed Web of Science ®Google Scholar